Predictive Oncology Inc. has announced the successful development of 3D organoid models specifically for Labcorp, which include unique human and rat liver toxicity models. These models are designed to ...
Predictive Oncology aims to enhance drug discovery using its biobank and AI, following industry trends exemplified by Regeneron's 23andMe acquisition. Predictive Oncology Inc. is leveraging its ...
Certis Oncology, an AI-enabled translational science company, today announced the launch of Certis Oncology Intelligence®, an integrated platform designed to generate data-driven insights into ...
Liver cancer is one of the world's deadliest malignancies, ranking as the third leading cause of cancer-related death. While advances in surgery have improved safety, recurrence after hepatectomy ...
Prediction of 48-hour intensive care unit mortality in hospitalized cancer patients: Accuracy of the EPIC deterioration index and sequential organ failure assessment score. This is an ASCO Meeting ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Predictive Oncology's latest ...
Forbes contributors publish independent expert analyses and insights. David Henkin helps organizations and individuals innovate and grow. Predictive analytics has evolved from a niche discipline into ...
Predictive modeling is reshaping how businesses anticipate challenges, seize opportunities, and optimize processes. By leveraging machine learning, ensemble methods, and advanced analytics, ...
Zohar Bronfman is the cofounder and CEO of Pecan AI, a predictive analytics platform making advanced AI accessible to business teams. For decades, predictive analytics was a capability largely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results